VisMed Medical (688580.SH) released its first three quarters performance, with net profit attributable to the parent company of 124 million yuan, a year-on-year increase of 21.36%.

Zhitong Finance APP News, Weisi Medical (688580.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 325 million yuan, a year-on-year decrease of 0.18%; net profit attributable to the parent company was 124 million yuan, a year-on-year increase of 21.36%; net profit after deducting non-recurring gains and losses was 88.28 million yuan, a year-on-year decrease of 5.68%; basic earnings per share were 1.30 yuan.